254 related articles for article (PubMed ID: 16266315)
1. Detection of prion epitopes on PrP and PrP of transmissible spongiform encephalopathies using specific monoclonal antibodies to PrP.
Yuan FF; Biffin S; Brazier MW; Suarez M; Cappai R; Hill AF; Collins SJ; Sullivan JS; Middleton D; Multhaup G; Geczy AF; Masters CL
Immunol Cell Biol; 2005 Dec; 83(6):632-7. PubMed ID: 16266315
[TBL] [Abstract][Full Text] [Related]
2. Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity.
Horiuchi M; Karino A; Furuoka H; Ishiguro N; Kimura K; Shinagawa M
Virology; 2009 Nov; 394(2):200-7. PubMed ID: 19766283
[TBL] [Abstract][Full Text] [Related]
3. Different antigenicities of the N-terminal region of cellular and scrapie prion proteins.
Ushiki-Kaku Y; Iwamaru Y; Masujin K; Imamura M; Itohara S; Ogawa-Goto K; Hattori S; Yokoyama T
Microbiol Immunol; 2013 Nov; 57(11):792-6. PubMed ID: 24117858
[TBL] [Abstract][Full Text] [Related]
4. Chicken antibody against a restrictive epitope of prion protein distinguishes normal and abnormal prion proteins.
Miyamoto K; Kimura S; Nakamura N; Yokoyama T; Horiuchi H; Furusawa S; Matsuda H
Biologicals; 2007 Oct; 35(4):303-8. PubMed ID: 17363268
[TBL] [Abstract][Full Text] [Related]
5. PrP glycoforms are associated in a strain-specific ratio in native PrPSc.
Khalili-Shirazi A; Summers L; Linehan J; Mallinson G; Anstee D; Hawke S; Jackson GS; Collinge J
J Gen Virol; 2005 Sep; 86(Pt 9):2635-2644. PubMed ID: 16099923
[TBL] [Abstract][Full Text] [Related]
6. Design and delivery of a cryptic PrP(C) epitope for induction of PrP(Sc)-specific antibody responses.
Hedlin PD; Cashman NR; Li L; Gupta J; Babiuk LA; Potter AA; Griebel P; Napper S
Vaccine; 2010 Jan; 28(4):981-8. PubMed ID: 19925901
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
[TBL] [Abstract][Full Text] [Related]
8. Characterization of conformation-dependent prion protein epitopes.
Kang HE; Weng CC; Saijo E; Saylor V; Bian J; Kim S; Ramos L; Angers R; Langenfeld K; Khaychuk V; Calvi C; Bartz J; Hunter N; Telling GC
J Biol Chem; 2012 Oct; 287(44):37219-32. PubMed ID: 22948149
[TBL] [Abstract][Full Text] [Related]
9. Vaccination with prion peptide-displaying papillomavirus-like particles induces autoantibodies to normal prion protein that interfere with pathologic prion protein production in infected cells.
Handisurya A; Gilch S; Winter D; Shafti-Keramat S; Maurer D; Schätzl HM; Kirnbauer R
FEBS J; 2007 Apr; 274(7):1747-58. PubMed ID: 17313482
[TBL] [Abstract][Full Text] [Related]
10. Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc.
Moroncini G; Kanu N; Solforosi L; Abalos G; Telling GC; Head M; Ironside J; Brockes JP; Burton DR; Williamson RA
Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10404-9. PubMed ID: 15240877
[TBL] [Abstract][Full Text] [Related]
11. Beta-PrP form of human prion protein stimulates production of monoclonal antibodies to epitope 91-110 that recognise native PrPSc.
Khalili-Shirazi A; Kaisar M; Mallinson G; Jones S; Bhelt D; Fraser C; Clarke AR; Hawke SH; Jackson GS; Collinge J
Biochim Biophys Acta; 2007 Nov; 1774(11):1438-50. PubMed ID: 17936697
[TBL] [Abstract][Full Text] [Related]
12. An antibody to the aggregated synthetic prion protein peptide (PrP106-126) selectively recognizes disease-associated prion protein (PrP) from human brain specimens.
Jones M; Wight D; McLoughlin V; Norrby K; Ironside JW; Connolly JG; Farquhar CF; MacGregor IR; Head MW
Brain Pathol; 2009 Apr; 19(2):293-302. PubMed ID: 18507665
[TBL] [Abstract][Full Text] [Related]
13. Antigenic characterization of an abnormal isoform of prion protein using a new diverse panel of monoclonal antibodies.
Kim CL; Umetani A; Matsui T; Ishiguro N; Shinagawa M; Horiuchi M
Virology; 2004 Mar; 320(1):40-51. PubMed ID: 15003861
[TBL] [Abstract][Full Text] [Related]
14. Mapping the prion protein using recombinant antibodies.
Williamson RA; Peretz D; Pinilla C; Ball H; Bastidas RB; Rozenshteyn R; Houghten RA; Prusiner SB; Burton DR
J Virol; 1998 Nov; 72(11):9413-8. PubMed ID: 9765500
[TBL] [Abstract][Full Text] [Related]
15. The use of monoclonal antibody epitopes for tagging PrP in conversion experiments.
Vorberg I; Pfaff E; Groschup MH
Arch Virol Suppl; 2000; (16):285-90. PubMed ID: 11214932
[TBL] [Abstract][Full Text] [Related]
16. Production and characterization of a panel of monoclonal antibodies against native human cellular prion protein.
Jones M; McLoughlin V; Connolly JG; Farquhar CF; MacGregor IR; Head MW
Hybridoma (Larchmt); 2009 Feb; 28(1):13-20. PubMed ID: 19132894
[TBL] [Abstract][Full Text] [Related]
17. Synthetic peptide vaccines yield monoclonal antibodies to cellular and pathological prion proteins of ruminants.
Harmeyer S; Pfaff E; Groschup MH
J Gen Virol; 1998 Apr; 79 ( Pt 4)():937-45. PubMed ID: 9568991
[TBL] [Abstract][Full Text] [Related]
18. Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state.
Horiuchi M; Caughey B
EMBO J; 1999 Jun; 18(12):3193-203. PubMed ID: 10369660
[TBL] [Abstract][Full Text] [Related]
19. Clearance and prevention of prion infection in cell culture by anti-PrP antibodies.
Pankiewicz J; Prelli F; Sy MS; Kascsak RJ; Kascsak RB; Spinner DS; Carp RI; Meeker HC; Sadowski M; Wisniewski T
Eur J Neurosci; 2006 May; 23(10):2635-47. PubMed ID: 16817866
[TBL] [Abstract][Full Text] [Related]
20. The octarepeat region of the prion protein is conformationally altered in PrP(Sc).
Yam AY; Gao CM; Wang X; Wu P; Peretz D
PLoS One; 2010 Feb; 5(2):e9316. PubMed ID: 20195363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]